Vascular origin of Kaposi's sarcoma. Expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor
- PMID: 7507301
- PMCID: PMC1887124
Vascular origin of Kaposi's sarcoma. Expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor
Abstract
We studied seven cases of Kaposi's sarcomas (KS) obtained from patients with AIDS and one KS from a patient without HIV infection. Antigen expression was studied by immunocytochemistry and mRNA expression by in situ hybridisation. The markers tested were endothelial leukocyte adhesion molecule-1, thrombomodulin, and tissue factor. In all tumors (AIDS and non-AIDS associated) these markers reacted positive, indicating transcription and translation of these genes in KS. The synthesis and expression of tissue factor and thrombomodulin suggests that KS is a tumor that has tissue factor-mediated thrombin formation under the control of thrombomodulin. The expression of thrombomodulin and endothelial leukocyte adhesion molecule-1 provides evidence for the vascular origin of KS.
Similar articles
-
Cultured Kaposi's sarcoma cell lines express factor XIIIa, CD14, and VCAM-1, but not factor VIII or ELAM-1.Arch Dermatol. 1993 Oct;129(10):1291-6. Arch Dermatol. 1993. PMID: 7692824
-
Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients.Am J Pathol. 1997 Mar;150(3):929-38. Am J Pathol. 1997. PMID: 9060831 Free PMC article.
-
Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells.J Pathol. 1994 May;173(1):23-31. doi: 10.1002/path.1711730105. J Pathol. 1994. PMID: 7523640
-
Epidemiology, etiology and pathogenesis, clinical presentations and therapeutic approaches in Kaposi's sarcoma: 15-year lessons from AIDS.Biomed Pharmacother. 1998;52(10):440-6. doi: 10.1016/S0753-3322(99)80022-5. Biomed Pharmacother. 1998. PMID: 9921413 Review.
-
The role of human immunodeficiency virus-I in the pathogenesis of acquired immunodeficiency syndrome-related Kaposi's sarcoma: the importance of an inflammatory and angiogenic milieu.Semin Oncol. 2000 Aug;27(4):420-3. Semin Oncol. 2000. PMID: 10950368 Review.
Cited by
-
Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease.Am J Pathol. 1995 Mar;146(3):688-94. Am J Pathol. 1995. PMID: 7887450 Free PMC article.
-
Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.J Clin Invest. 1995 Apr;95(4):1723-34. doi: 10.1172/JCI117849. J Clin Invest. 1995. PMID: 7535796 Free PMC article.
-
Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.Am J Pathol. 1998 Jun;152(6):1433-43. Am J Pathol. 1998. PMID: 9626048 Free PMC article.
-
Coexistence of intestinal Kaposi sarcoma and plasmablastic lymphoma in an HIV/AIDS patient: case report and review of the literature.J Gastrointest Oncol. 2016 Apr;7(Suppl 1):S88-95. doi: 10.3978/j.issn.2078-6891.2015.021. J Gastrointest Oncol. 2016. PMID: 27034819 Free PMC article.
-
Therapeutic Antibody-Like Immunoconjugates against Tissue Factor with the Potential to Treat Angiogenesis-Dependent as Well as Macrophage-Associated Human Diseases.Antibodies (Basel). 2018 Mar;7(1):8. doi: 10.3390/antib7010008. Epub 2018 Jan 23. Antibodies (Basel). 2018. PMID: 31105982 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical